KB-707

N/A

Report date: 2026/02/12 15:12:07

Base Information

Drug NameKB-707
Drug Alias NameGenetically modified herpes simplex type 1 virusKB-707KB707
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Herpes simplex virus vectorBiologics > Oncolytic virus
Mechanisms of ActionInterleukin-2 modulatorsInterleukin-12 receptor modulators
TargetsInterleukin-2Interleukin-12 receptor
Therapy Area/IndicationsSkin MelanomaSolid tumoursCarcinoma, Non-Small-Cell Lung +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesKrystal Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesKrystal Biotech Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungLung Neoplasms +[4] 
Inactive IndicationsSkin MelanomaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A